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Abstract 
The intestinal messenger RNA expression signature is affected by the presence and compo-
sition of the endogenous microbiota, with effects on host physiology. The intestine is also 
characterized by a distinctive micronome. However, it is not known if microbes also impact 
intestinal gene expression epigenetically. We investigated if the murine caecal microRNA 
expression signature depends on the presence of the microbiota, and the potential implica-
tions of this interaction on intestinal barrier function. Three hundred and thirty four mi-
croRNAs were detectable in the caecum of germ-free and conventional male mice and 16 
were differentially expressed, with samples from the two groups clustering separately based 
on their expression patterns. Through a combination of computational and gene expression 
analyses, including the use of our curated list of 527 genes involved in intestinal barrier reg-
ulation, 2,755 putative targets of modulated microRNAs were identified, including 34 intes-
tinal barrier-related genes encoding for junctional and mucus layer proteins and involved in 
immune regulation. This study shows that the endogenous microbiota influences the caecal 
microRNA expression signature, suggesting that microRNA modulation is another mecha-
nism through which commensal bacteria impact the regulation of the barrier function and 
intestinal homeostasis. Through microRNAs, the gut microbiota may impinge a much larger 
number of genes than expected, particularly in diseases where its composition is altered. In 
this perspective, abnormally expressed microRNAs could be considered as novel therapeutic 
targets. 
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Introduction 
Humans  are  complex  supra-organisms  com-
posed  of various endosymbionts that stem from all 
three domains of life including bacteria, archaea, and 
eukarya in addition to their own cells. Body habitats 
that are considered “hot spots” for microbial coloni-
zation include the skin, oral cavity, gut and urogenital 
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tract [1,2]. However, in utero, the fetus is completely 
sterile with colonization beginning postnatally. It  is 
this developmental property that enables for the ex-
ploitation of germ-free animals, which are devoid of 
microbes on or within their body, in order to deter-
mine  the  functional  properties  of  host  endogenous 
microbiota. 
In  fact,  the  gastrointestinal  (GI)  tracts  of  both 
humans  and  conventionally  raised  mice  harbor  up-
wards of 1014 micro-organisms with levels increasing 
along the cephalocaudal axis. Temporo-spatially the 
organization  of  bacterial  cohorts  differs  with  the 
largest densities residing in the large intestine, with 
the caecum acting as a fermentation chamber where 
upwards of 1011-1012 bacteria/gram luminal contents 
ferment otherwise indigestible polysaccharides lead-
ing to the production of short chain fatty acids. The 
predominant bacteria groups found in human caecal 
fluid  stems  from  the  E.  coli  and  Lactobacil-
lus-Enterococcus  groups  that  represent  50%  of  the 
caecal  bacterial  ribosomal  Ribonucleic  Acid  (rRNA) 
whereas,  Bacteroides  (Bacteroides,  Porphyromonas  and 
Prevotella  spp.)  and  Clostridium  groups  (Clostridium, 
Eubacterium and Ruminococcus spp.) represent 13% of 
caecal bacterial rRNA [3]. Similarly, the murine caecal 
microbiota  establishes  gradually  during  early  post-
natal life, and its complexity increases with age until a 
mature  community  is  reached  by  4-6  weeks  of  age 
predominately comprising the  Bacteroides and Lacto-
bacillus genera and the Clostridium coccoides group [4]. 
The  microbiota  residing  along  the  alimentary  canal 
takes advantage of a continuous supply of nutrients 
and optimal temperature while playing a pivotal role 
in host physiology, including nutrient processing and 
generation,  affecting  energy  homeostasis,  education 
of  the  immune  system,  and  fortifying  the  intestinal 
barrier  both  directly  and  indirectly  [5].  One  of  the 
mechanisms underlying this host-microbe mutualistic 
relationship is the reciprocal impact of host and mi-
crobial cells on each other’s gene expression programs 
[6,7]. In particular, the endogenous microbiota acts as 
an environmental factor impacting the expression of 
thousands genes in the host epithelium [8,9], and this 
is a function of its composition [9,10]. However, the 
impact  of  the  microbiota  on  the  intestinal  gene  ex-
pression signature at the messenger RiboNucleic Acid 
(mRNA)  level  may  have  thus  far  been  un-
der-evaluated due to a lack of studies linking gut mi-
crobiota  to  epigenetic  changes  in  gene  expression 
particularly, via micro-RiboNucleic Acids (miRNA).  
MiRNAs  are  20-22  nucleotide,  single-stranded, 
non-coding  RNA  molecules  involved  in 
post-transcriptional gene regulation. Nascent miRNA 
exist  as  large  hairpin-loop  precursor  structures  that 
undergo several stages of enzymatic processing. Pre-
cursor  miRNA  molecules  are  first  generated  in  the 
nucleus and then exported into the cytosol where they 
are processed by the enzyme Dicer to form  shorter 
duplexes, with one of the two single-stranded mole-
cules  being  incorporated  as  part  of  the  molecular 
machinery involved in post-transcriptional gene reg-
ulation  while  the  other,  passenger  strand  (usually 
indicated with *), is short-lived and rapidly degraded. 
The association between the single-stranded miRNA 
molecule and the enzymatic complex RNA Induced 
Silencing  Complex  (RISC)  lends  to  translational  re-
pression, or cleavage of the targeted mRNA via com-
plementary base pairing to the three prime untrans-
lated region (3’UTR) of their target mRNAs, with the 
degree  of  complementarity  dictating  the  fate  of  the 
target [11]. What has come to light in recent years is 
that  miRNAs  can  also  induce  the  up-regulation  of 
gene expression through interactions with genes that 
contain  complementary  binding  sequences  in  their 
promoter regions [12]. To date, 1,048 miRNAs have 
been annotated in humans and 672 in mice (miRBase 
release 16, 2010) [13] with the true number suggested 
to be well over 1,000 miRNAs that are encoded in the 
mammalian genome [14]. Indeed, it is estimated that 
these short non-coding RNA molecules regulate up to 
50% of the transcriptome (protein encoding mRNAs) 
[15], however, the true breadth of their potential lies 
in the fact that each  miRNA can have hundreds  of 
targets [16] and in retrospect, multiple miRNAs can 
have  the  same  mRNA  targets.  These  properties  of 
miRNAs suggest that a single miRNA can potentially 
influence  multiple  biological  pathways  [17].  In  fact, 
miRNAs  whose  expression  is  tissue  and  develop-
mentally regulated [18], have been shown to affect a 
broad  range  of  biological  processes  in  plants  and 
animals including; development, differentiation, cell 
proliferation,  apoptosis  [19],  regulation  of  innate 
immunity [20] and defense from viruses and patho-
gens [21,22].  
Whilst few studies have investigated the mam-
malian intestinal miRNA signature, a recent analysis 
of  the  global  porcine  micronome  demonstrated  the 
expression of 332 miRNAs along the intestinal tract 
with region-specific expression along the longitudinal 
gut axis [23]. In line with these findings, upwards of 
200 known mature miRNAs and 122 miRNA* species 
were identified in colorectal cell lines [24] with some 
found in following clinical studies to have a greater 
affinity  for  expression  in  specific  regions  and  most 
expressed globally in the human GI tract [25]. Intes-
tinal miRNAs have experimentally proven biological 
roles ranging from the regulation of neonatal nutrient 
metabolism [26] to the control of intestinal fluid and Int. J. Biol. Sci. 2012, 8 
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electrolyte  transport  [27]  and  permeability  [28],  be-
sides affecting intestinal epithelial cell differentiation 
[29] and maturation [30].  
The intestinal miRNA signature has been found 
to be deregulated in various disease states. MiRNAs 
can display both oncogenic or tumor suppressive ef-
fects in several types of cancers [31], and recently 11 
miRNAs were found to be differentially expressed in 
the sigmoid colon of patients with active ulcerative 
colitis (UC) versus healthy controls [32], with effects 
on secretion of pro-inflammatory chemokines [32].  
In  addition,  both  plants  and  animals  differen-
tially  express  miRNAs  following  sensing  of  patho-
gen-associated  molecular  patterns  (PAMPs).  For  in-
stance,  bacterial  flagellin-induced  upregulation  of 
miR-393 in Arabidopsis thaliana participates in the reg-
ulation of the host defense system [22]. In animals, 
specific miRNAs are induced in response to various 
bacterial  components,  such  as  lipopolysaccharide 
(LPS) in monocytes [33] and to viral infection such as 
in Hepatitis B and C [34]. Moreover, miR-155 is up-
regulated in gastric epithelial cells following  Helico-
bacter  pylori  infection  [35].  All  of  these  changes  re-
sulted in downstream regulation of the immune re-
sponse. 
It has been recently suggested that the onset of 
several  intestinal  diseases  including  Inflammatory 
Bowel  Disease  (IBD)  and  Irritable  Bowel  Syndrome 
(IBS), are caused by both deregulation of the intestinal 
barrier function and by microbial factors [36,37], but 
how the two intertwine to affect such conditions is not 
well  understood.  The  intestinal  barrier  is  a  mul-
ti-tiered line of defense localized at the interface be-
tween the external environment and internal milieu 
and  comprises  physical,  chemical  and  recep-
tor-mediated pathogen sensing components [38]. The 
endogenous gut microbiota is an important constitu-
ent of the barrier in that it not only participates in the 
formation  of  the  physical  and  chemical  barrier  via 
pathogen exclusion, antimicrobial peptide secretion, 
and immuno-modulation, but also acts as a vector of 
change  by  modulating  the  mRNA  expression  of  a 
number of genes involved in intestinal barrier func-
tion [9,7]. However, the epigenetic basis of these in-
teractions is yet to be elucidated as there is a lack of 
studies  evaluating  modulation  of  host  miRNAs  in 
response to symbiotic microorganisms. Intriguingly, 
legumes  miRNAs  are  modulated  during  the  estab-
lishment and maintenance of the rhizobia symbiosis 
in root nodules [39]. Though, it is unknown if this is 
also  true  for  animals  who  live  in  a  symbiotic  rela-
tionship with complex microbial communities at var-
ious body sites such as the intestine. 
We  used  germ-free  and  conventionally  raised 
mice to investigate the impact of the endogenous mi-
crobiota on the global expression of caecal miRNAs in 
vivo. We show that the murine miRNA signature in 
the  caecum  is  comprised  of  several  variously  ex-
pressed species and that it is indeed affected by the 
presence of the microbiota. Moreover, we show that 
several of the putative mRNA targets of the modu-
lated miRNAs encode for genes known to be involved 
in  the  regulation  of  the  intestinal  barrier  function, 
including glycosylation enzymes, junctional proteins, 
proteins  found  in  the  mucus  layers  and  genes  in-
volved in immune regulation. 
Materials and Methods 
Animals 
Swiss Webster male mice were used according to 
the Regulations  of the Animals for  Research Act in 
Ontario and the Guidelines of the Canadian Council 
on Animal Care. Animal study design and procedures 
were approved by the animal ethics committee at the 
University of Toronto (Animal Use Protocol Number: 
20008318).  Five  germ-free  and  five  conventionally 
raised mice, 6 weeks of age, were obtained from Ta-
conic Farms (Germantown, NY), sacrificed via cervi-
cal dislocation and then dissected in sterile conditions. 
Upon  sacrifice,  the  entire  caecum  was  immediately 
excised  and  caecal  contents  were  collected.  Caecal 
tissues were further cleaned with sterile 0.9 % NaCl, 
divided into two halves longitudinally, snap-frozen in 
liquid nitrogen and stored at -80°C until further pro-
cessing. Caecal contents were immediately fixed in 4% 
paraformaldehyde and used to confirm the germ-free 
status of the animals by Fluorescence in situ Hybridi-
zation  with  the  EUB338  5’-Cy3  labeled  16S  rRNA 
probe  specific  for  all  bacteria  (5’/5Cy3/GCT  GCC 
TCC CGT AGG AGT-3’) (Integrated DNA Technolo-
gies), as previously described [40].  
RNA extraction 
Small RNA-containing total RNA was extracted 
from  one-half  segment  of  the  caecum  from  both 
germ-free (n = 5) and conventionally-raised (n  = 5) 
mice, using miRVANATM miRNA Isolation Kit (Am-
bion,  Austin,  TX,  USA),  as  per  the  manufacturer’s 
instructions, eluted in 100 µl of RNAse-free water and 
stored at -80°C. Recovered total RNA concentration 
and purity were spectrophotometrically assessed us-
ing  Thermoscientific’s  Nanodrop  1000  Spectropho-
tometer  (Nanodrop  Technologies,  Wilmington,  DE, 
USA)  and  ranged  between  2.13-2.16  and  2.01-2.12, 
respectively. RNA integrity was confirmed by dena-
turing agarose gel electrophoresis.  Int. J. Biol. Sci. 2012, 8 
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Global microRNA expression profiling 
cDNA was synthesized from 1 µg of total RNA 
(n = 3 per group) using the Taqman® MicroRNA Re-
verse  Transcription  Kit  in  conjunction  with  Rodent 
Megaplex™ Primer Pools according to the manufac-
turer’s protocol (Applied Biosystems, CA, USA). The 
Rodent Megaplex™ Primer Pools contains two sets of 
microRNA-specific RT primers, pools A and B, that 
enable  for  the  RT  of  375  microRNAs/6  spe-
cies-specific  controls  and  210  microRNAs/6  spe-
cies-specific controls, respectively. Separate reactions 
were run for pools A and B in Applied Biosystems’ 
GeneAmp® PCR System 2700 Thermocycler. Global 
microRNA  expression  profiling  was  conducted  by 
TaqMan quantitative PCR using Applied Biosystems’ 
Taqman® Rodent MicroRNA Array Set v2.0 (Taqman 
Low Density Arrays, TLDAs) that comprise two mi-
crofluidic cards (plates A and B) containing a total of 
384  Taqman®  Assays  per  card  (some  of  which  are 
duplicate probes). cDNA products from the Megaplex 
RT  pools  set  were  independently  assessed  on  both 
microfludic cards with plate A enabling for the sim-
ultaneous quantification of 375 microRNA targets/6 
controls while plate B, 210 microRNA targets/6 con-
trols.  The  protocol  suggested  by  the  manufacturer 
was followed. Real-Time PCR was performed using 
an Applied Biosystems 7900 HT Real-Time PCR sys-
tem  and  default  thermal-cycling  conditions  for 
384-wells Taqman Low Density Arrays. 
Real-Time PCR validation of individual mi-
croRNAs expression 
Ten ng of total RNA (n=5 per group) was reverse 
transcribed  with  the  Taqman®  MicroRNA  Reverse 
Transcription  Kit  and  primers  specific  for  miR-455 
(Assay  ID:  002455)  and  the  endogenous  control 
snoRNA135 genes (Assay ID: 001230) (Applied Bio-
systems)  in  Applied  Biosystems’  GeneAmp®  PCR 
System  2700  Thermocycler  according  to  the  manu-
facturer’s  protocol.  Real  time  PCR  was  then  con-
ducted  using  undiluted  cDNA,  TaqMan  MicroRNA 
Assays  (miR-455  assay  ID:  002455  and  snoRNA135 
assay ID: 001230) and the TaqMan 2X Universal PCR 
Master  Mix,  No  AmpEraseUNGa  (Applied  Biosys-
tems) in a 10 µl PCR reaction. Each reaction was run in 
triplicates in a 384-well optical plate in Applied Bio-
systems’ 7900 HT Real-Time PCR machine using the 
9600 emulation mode with an initial hold at 95°C for 
10 minutes followed by 40 cycles of 95°C for 15 se-
conds,  and  60°C  for  60  seconds.  Results  were  ex-
pressed as fold change between germ-free and con-
ventional  mice  as  calculated  by  ΔΔCt  method  [41] 
after  normalization  to  sno-135  gene,  which  was 
shown to be equally expressed in the caeca of the two 
groups  of  mice  by  the  TLDA  experiments.  Signifi-
cance  of  differential  gene  expression  was  assessed 
with the Mann-Whitney test using GraphPad Prism 5 
Software (La Jolla, CA, USA). 
Analysis of TLDA data 
Raw data were pre-processed in SDS 2.3 for in-
dividual plates and then concurrently for all plates in 
SDS  RQ  Manager  1.2  (Applied  Biosystems)  for  the 
generation  of  Ct  (Cycle  threshold)  values.  A 
pre-selection filter was applied to all miRNA TLDA 
data to reduce noise in the dataset and to reduce the 
severity  of  the  multiple  testing  adjustment.  To  this 
end, any miRNA not meeting both of the following 
criteria were removed from further analysis: a) Pres-
ence in all three of either conventional samples or the 
germ-free  group;  b)  Presence  in  at  least  one  of  the 
conventional samples to enable the ΔΔCt method to 
be used for normalization. Following pre-filtering, all 
duplicate probes for the same miRNA species on the 
same plate were averaged and the mean Ct value was 
utilized for further analysis. Data were then normal-
ized by “columnwise mean” normalization, such that 
the target miRNA is normalized to the mean Ct of all 
miRNA  for  each  sample,  a  method  that  has  been 
suggested  as  an  improvement  for  high-throughput 
miRNA  Quantitative  PCR  (qPCR)  [42]  where  the 
mean abundance of hundreds of targets may be more 
stable  than  any  endogenous  control  across  samples 
and  experimental  groups.  To  identify  differentially 
expressed genes, the empirical Bayes-moderate t-test 
was used as implemented in the LIMMA R package 
[43].  For  this  approach,  missing  Ct  values  were  as-
sumed to be unknown rather than imputed to 40, to 
avoid  creating  a  bimodal  distribution  of  Ct  values, 
which  would  violate  the  assumption  of  the  t-test. 
False discovery rate was calculated by the method of 
Benjamini  and  Hochberg,  as  implemented  in  the  R 
package multtest (Pollard et al., v.1.22.0). Supervised 
heatmaps  were  created  using  the  R  package  gplots. 
Clustering  in  the  heatmaps  is  based  on  complete 
linkage and Euclidean as the distance metric, using 
default  setting  for  the  hclust  (hierarchical  cluster) 
function in R [44].  
Analysis was performed in the R language and 
environment  for  statistical  computing  (R  Develop-
ment Core Team, 2008, v2.8.1) [45].  
MiRNAs target prediction 
To investigate the relationship between selected 
miRNAs  of  interest  and  the  genes  that  they  poten-
tially target, we mapped them into a miRNA network 
using NAViGaTOR ver. 2.2 [46]. We first used high 
precision  miRNA:target  relationships  in  mouse  - Int. J. Biol. Sci. 2012, 8 
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taken from the TargetScan Conserved Targets (Con-
served_Sites_Context_Scores.txt  Release  5.1) 
[47,48,49]  or  PITA  TOP  database  predictions 
(PITA_targets_mm9_0_0_TOP.tab.gz,  May  2010 
download)  [50].  Previous  work  examining  miR-
NA:target relationships suggests that both PITA and 
TargetScan provide high quality interactions suitable 
for  the  construction  of  an  interaction  network  [51]. 
Genes identified by this first analysis were then fil-
tered based on their inclusion in an intestinal barrier 
gene set to assess the potential impact of differentially 
expressed miRNAs on the intestinal barrier function. 
A subset of 527 genes important in maintenance of the 
intestinal barrier function were identified and classi-
fied according to function - mainly physical, chemical 
and pathogen sensing components as per Cummings 
J. H., et al. [38] (Additional file 5: Table S5). Identified 
miRNA  target  genes  were  filtered  by  the  intestinal 
barrier  set  prior  to  being  mapped  into  the  miRNA 
network. This reduced the number of initial miRNA 
target genes of the 11 miRNAs with predicted targets 
from 2,755 in the general setting to 34 present in the 
intestinal barrier setting. 
Analysis of miRNA potential targets biological 
function 
To further understand the functions of gene tar-
gets of miRNAs with altered expression in this study, 
we examined all 2,755 gene targets of the 11 miRNAs 
prior to the filtering step. Using the Panther Classifi-
cation System Version 7.0 [52,53], we examined the 
over- or under- representation of our miRNA target 
genes compared to a universe consisting of all genes 
listed as miRNA targets in the PITA Top Targets or 
TargetScan Conserved Targets (as discussed above). 
Categories examined include Gene Ontology Classes: 
Biological  Processes,  Molecular  Function,  Cellular 
Component as well as Pathway Analysis and Protein 
Class Analysis. 
Results 
Differential expression of miRNAs in the cae-
cum of germ-free and conventionally raised 
mice 
To assess if the caecal miRNA expression signa-
ture is associated with the presence of the endogenous 
microbiota, we examined small RNA-containing total 
RNA extracted from the caecum of germ-free (n=3) 
and  conventionally  raised  mice  (n=3).  Each  sample 
was independently run on two different Taqman Low 
Density  Arrays  (Plates  A  and  B),  which  combined 
allow  for  the  analysis  of  585  mature  miRNAs.  Fif-
ty-seven  percent  of  the  targeted  miRNAs  were  de-
tectable  (Ct<35)  in  the  caeca  of  both  germ-free  and 
conventionally  raised  mice  (Additional  file  1:  Table 
S1). Ranked mean abundance of miRNAs was similar 
for both groups of mice (Spearman R=0.74, P< 0.0001, 
95% CI= 0.68 to 0.78) (Figure 1). 
 
 
Figure 1. Caecal global microRNA expression is correlated in germ-free and conventional mice. Scatter plot depicting the 
relationship between global miRNA expression levels of 336 miRNAs in germ-free (GF) and conventional (Conv) caecal samples 
(n=3/group) as assessed by qRT-PCR and TLDA plates A and B. Data are presented as mean delta Ct values for each miRNA (mean delta 
Cts represent the average delta Ct for all three samples/group, with each individual Ct normalized by mean expression value normalization 
procedure). Of the 585 miRNA species analyzed, 336 remained after filtering and normalization, as explained in Materials and Methods and 
were used in subsequent analyses. Int. J. Biol. Sci. 2012, 8 
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We found 18 transcripts differentially expressed 
between  the  two  groups,  including  both  up-  and 
down-regulated  miRNAs  with  a  fold  change 
(germ-free vs. conventional) ranging between 0.2 and 
4.6 (Table 1) (False Discovery Rate = 0.2). These cor-
respond  to  16  unique  miRNAs,  including 
mmu-miR-351 and rno-miR-351 - two sequences con-
served in mouse and rat - while Y1 is a rat endoge-
nous  small  RNA.  A  second  rat  miRNA  species, 
rno-miR-664,  was  found  to  be  significantly 
up-regulated by 2.85-fold in germ-free samples. The 
murine  homolog,  mmu-miR-664,  is  not  represented 
on the TLDA plates that we used. Sequence analysis 
using  miRviewer  [54]  demonstrates  that  miR-664-1 
shows  sequence  similarity  in  rat,  mouse  and  horse 
with a greater conservation amongst rat and mouse. 
Therefore, it is likely that the measured signal is bio-
logically  reliable  and  derives  from  cross-reaction  of 
the rno-miR-664 TaqMan assay with the homologous 
murine miRNA species. Five of the sixteen transcripts 
correspond to passenger miRNA (miRNA*) sequenc-
es.  Up-regulation  of  miR-455  in  germ-free  versus 
conventional  mice  was  confirmed  in  a  separate  ex-
periment using gene-specific single-well TaqMan PCR 
and  RNA  from  the  caecum  of  five  mice  per  group 
(fold  change  germ-free  versus  conventional=1.7, 
Mann-Whitney test p=0.0079).  
 
Table 1. Differentially expressed microRNA in germ-free versus conventional mice. Real-time PCR analysis of the global 
expression of microRNAs in the caecum of germ-free (GF) (n=3) versus conventional (CONV) mice (n=3). Fold-change and statistical 
significance were calculated after mean expression value normalization. Statistical significance is based on Bayes-moderated t-test with a 
FDR of 20%. In total 18 transcripts were found to be differentially expressed between the two groups with 16 unique mature microRNAs 
(Y1 is a rat endogenous small RNA). Fold change corresponds to the ratio of mean expression of the microRNA in GF mice to mean 
expression in CONV mice. Values < 1 indicate lower expression in GF (down-regulated in GF mice compared to CONV mice), whereas 
values > 1 indicate higher expression in GF (up-regulated in GF mice compared to CONV mice). Genomic locations and corresponding 
microRNA sequences (5’ – 3’) are based on miRBase version 16. Homology of microRNA sequences between diverse species is derived 
from miRviewer (last updated November 9, 2008). 
miRNA  Fold  
GF vs. 
Conv 
Adjusted  
P-values 
Genomic Location  Mature miRNA Sequence  
(5’ – 3’) 
Homology 
mmu-miR-21*   0.20  0.06  chr11: 86397569-86397660 [-]  56 -CAACAGCAGUCGAUGGGCUGUC - 77  NA  
rno-miR-351   0.31  0.06  chrX: 139999130-139999210 [-]  16 -UCCCUGAGGAGCCCUUUGAGCCUGA- 40  Mmu, Rno  
mmu-miR-351   0.33  0.20  chrX: 50406432-50406530 [-]   16 -UCCCUGAGGAGCCCUUUGAGCCUG- 39   Mmu, Rno  
mmu-miR-487b   0.45  0.12  chr12: 110965543-110965624 
[+]  
50 -AAUCGUACAGGGUCAUCCACUU- 71   Mmu, Rno, Hsa, Ptr, Mml, 
Str, Bta, Laf  
mmu-miR-467a -1 
mmu-miR-467a -2  
mmu-miR-467a -3  
mmu-miR-467a -4  
mmu-miR-467a -5  
mmu-miR-467a -6  
mmu-miR-467a -7  
mmu-miR-467a -8  
mmu-miR-467a -9  
mmu-miR-467a -10  
0.47  0.06  chr2: 10397973-10398045 [+] 
chr2: 10400425-10400507 [+] 
chr2: 10405305-10405387 [+] 
chr2: 10407762-10407844 [+] 
chr2: 10410226-10410308 [+] 
chr2: 10412675-10412757 [+] 
chr2: 10415137-10415219 [+] 
chr2: 10417607-10417689 [+] 
chr2: 10420020-10420102 [+] 
chr2: 10424900-10424982 [+] 
10 -UAAGUGCCUGCAUGUAUAUGCG- 31  
15 -UAAGUGCCUGCAUGUAUAUGCG- 36  
15 -UAAGUGCCUGCAUGUAUAUGCG- 36  
15 -UAAGUGCCUGCAUGUAUAUGCG- 36  
15 -UAAGUGCCUGCAUGUAUAUGCG- 36  
15 -UAAGUGCCUGCAUGUAUAUGCG- 36  
15 -UAAGUGCCUGCAUGUAUAUGCG- 36  
15 -UAAGUGCCUGCAUGUAUAUGCG- 36  
15 -UAAGUGCCUGCAUGUAUAUGCG- 36  
15 -UAAGUGCCUGCAUGUAUAUGCG- 36  
Mmu  
mmu-miR-27b*   0.54  0.16  chr13: 63402020-63402092 [+]   7 -AGAGCUUAGCUGAUUGGUGAAC- 28   NA  
mmu-miR-148a   0.58  0.12  chr6: 51219811-51219909 [-]   61 -UCAGUGCACUACAGAACUUUGU- 82   Mmu, Hsa, Ptr, Ppy, Mml, 
Oga, Cpo, Ocu, Opr, Bta, 
Cfa, Eca, Eeu, Fca, Laf, Tbe, 
Mlu, Mdo, Gga, Xtr  
mmu-miR-145   1.52  0.17  chr18: 61807479-61807548 [-]   7 -GUCCAGUUUUCCCAGGAAUCCCU - 29   Mmu, Rno, Hsa, Ptr, Ppy, 
Mml, Mim, Oga, Cpo, 
Ocu, Opr, Sar, Str, Bta, 
Cfa, Dno, Eca, Eeu, Ete, 
Fca, Tbe, Mlu, Mdo, Oan, 
Dre, Gac, Tru, Xtr  
mmu-miR-183   1.56  0.17  chr6: 30119668-30119737 [-]   6 -UAUGGCACUGGUAGAAUUCACU- 27   Mmu, Rno, ,Hsa, Ptr, Ppy, 
Mml, Mim, Oga, Opr, Sar, 
Str, Bta, Cfa, Dno, Eca, 
Ete, Fca, Tbe, Mlu, Mdo, 
Oan, Gga, Dre, Gac, Ola, 
Tni, Tru, Xtr, Cin  
mmu-miR-133a -1  
mmu-miR-133a-2  
1.61  0.12  chr18: 10782907-10782974 [-]  
chr2: 180133084-180133187 [+] 
43 -UUUGGUCCCCUUCAACCAGCUG- 64 
59 -UUUGGUCCCCUUCAACCAGCUG- 80 
miR-133a-1: Mmu, Hsa, 
Ptr, Cpo, Ocu, Opr, Sar, 
Str, Bta, Cfa, Dno, Eca, 
Eeu, Ete, Fca, Tbe, Gga, 
Dre, Gac, Ola, Tru Int. J. Biol. Sci. 2012, 8 
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miR-133a-2: Mmu, Hsa, 
Ptr, Gga, Dre  
mmu-miR-150   1.66  0.15  chr7: 52377127-52377191 [+]   6 -UCUCCCAACCCUUGUACCAGUG- 27   Mmu, Rno, Hsa, Ptr, Ppy, 
Mml, Mim, Opr, Sar, Str, 
Bta, Cfa, Eca, Fca, Tbe, 
Oan, Dre, Ola, Xtr  
Y1-4386739.B   2.02  0.15  NA   NA   NA  
mmu-miR-672   2.74  0.06  chrX: 101311514-101311613 [-]   25 -UGAGGUUGGUGUACUGUGUGUGA- 47   Mmu, Rno, Mim, Oga, 
Cpo, Ocu, Str, Dno, Eca, 
Ete, Cin  
mmu-miR-181a-1*   2.79  0.17  chr1: 139863032-139863118 [+]   54 -ACCAUCGACCGUUGAUUGUACC- 75   NA  
rno-miR-664 -1 
rno-miR-664-2  
2.85  0.06  chr18: 47881354-47881412 [+]  
chr13: 101253993-101254051 
[+]  
38 -UAUUCAUUUACUCCCCAGCCUA- 59  
38 -UAUUCAUUUACUCCCCAGCCUA- 59  
miR-664-1: Mmu, Rno, 
Eca  
miR-664-2: Rno, Laf 
mmu-miR-455   3.00  0.15  chr4: 62917885-62917966 [+]   54 -GCAGUCCACGGGCAUAUACAC- 74   Mmu, Rno, Hsa, Ptr, Ppy, 
Mml, Mim, Oga, Cpo, 
Ocu, Opr, Str, Bta, Cfa, 
Eeu, Ete, Fca, Laf, Mlu, 
Mdo, Gga, Dre, Gac, Ola, 
Tni, Tru, Xtr  
mmu-miR-138*   4.43  0.12  chr9: 122591994-122592092 [+]   61 -CGGCUACUUCACAACACCAGGG- 82   NA  
mmu-let-7g*   4.60  0.10  chr9: 106081171-106081258 [+]   63 -ACUGUACAGGCCACUGCCUUGC- 84   NA  
 
 
Analysis of miRNA conservation and their ge-
nomic  contexts  revealed  that  all  of  the  significantly 
differently expressed miRNAs belong to various fam-
ilies and cluster separately in terms of their genomic 
locations with the exception of miR-351 in which both 
rat  miRNA  (rno-miR-351),  and  murine  miRNA 
(mmu-miR-351)  were  found  to  belong  to  the  same 
mir-351 family, based on sequence conservation [13].  
Furthermore, supervised hierarchical clustering 
analysis  using  the  18  differentially  expressed  tran-
scripts  demonstrated  intra-group  similarities  in 
miRNA  expression  with  inter-group  variation  in 
miRNA expression (Figure 2), showing that the caecal 
miRNA signatures cluster according to the presence 
or absence of the endogenous microbiota.  
Experimentally verified and predicted mRNA 
targets of the differentially expressed miRNAs 
Based on Tarbase V5.0 [55] and miRecords V2.0 
[56],  two  freely  available  databases  that  provide  a 
repository  of  information  pertaining  to  experimen-
tally validated miRNA targets in several animal spe-
cies,  plants  and  viruses,  six  (miR-133a,  miR-672, 
miR-183, miR-148a, miR-145, miR-150) of the sixteen 
differentially expressed miRNAs have experimentally 
verified mRNA targets (Additional file 2: Table S2). Of 
these  mRNA  targets,  seven  (Serum  response  factor 
(Srf), Ras homolog gene family, member A (Rhoa), Cell 
division  cycle  42  homolog  (S.  cerevisiae)  (Cdc42), 
Peroxiredoxin  6  (PRDX6),  Homeo  box  A9  (Hoxa9), 
Vascular  endothelial  growth  factor  A  (Vegfa),  and 
Myeloblastosis oncogene (Myb) were detected with a 
signal  intensity  higher  than  150  in  microarray  ex-
periments  analyzing  gene  expression  in  C57BL/6 
mice caeca (n=2) (Gene Expression Omnibus [57] da-
taset  GSE1133  [58]).  Therefore,  based  on  the  miR-
NA/mRNA co-expression criterion for target valida-
tion [59], these genes are good candidates for micro-
biota-dependent expression modulation via miRNA.  
However, each miRNA species is likely to have 
multiple  physiologically  relevant  targets,  most  of 
which are unknown, and several algorithms can be 
employed for their in silico identification. To predict 
targets for the 16 miRNAs found to be differentially 
expressed between germ-free and conventional mice, 
we  adopted  a  conservative  approach.  We  extracted 
target predictions from 2 sources: Probability of In-
teraction by Target Accessibility (PITA) [50] and Tar-
getScan [47,48,49]; thus, our target prediction sets are 
based  on  several  criteria  including  conservation  of 
target binding sites and the degree of accessibility of 
the  three  prime  untranslated  regions  of  the  mRNA 
target.  Two  thousand  seven  hundred  and  fifty-five 
unique genes were found to map as targets of these 
miRNAs as predicted by both algorithms (Additional 
file  3:  Table  S3).  These  genes  were  mapped  to 
PANTHER  database  [52]  to  assess  their  group  de-
scriptors.  We  first  considered  the  Gene  Ontology 
classifications and found our gene list to be signifi-
cantly  enriched  in  several  categories:  (1)  biological 
processes  including  development,  cell  communica-
tion,  signal  transduction  (all  at  p<0.0001),  among 
others; (2) molecular functions including DNA, tran-
scription  factor,  protein  binding  (all  at  p<0.0001), 
among  others;  and  (3)  cellular  components  such  as 
actin cytoskeleton (p<0.0001) (Additional file 4: Table 
S4). Next, we found our targets enriched in the Wnt 
signaling  pathway,  angiogenesis,  transforming Int. J. Biol. Sci. 2012, 8 
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growth  factor-beta  (TGF-β)  and  cadherin  signaling 
pathways and in the transcription factors protein class 
followed by enzyme  modulator and ribosomal pro-
teins (all at p<0.0001), among others (Additional file 4: 
Table S4). Several of the 2,755 global putative targets 
of the differentially expressed miRNAs were found to 
map to diverse components of the intestinal barrier 
function  when  assessing  gene  ontologies.  These  in-
clude; (1) Biological Processes such as cell-cell adhe-
sion (p<0.0001), immune system processes (p<0.001) 
encompassing  antigen  processing  and  presentation 
(p<0.01)  and  defense  response  to  bacterium  (p<0.2) 
amongst  others;  (2)  Molecular  Functions  including 
structural constituents of cytoskeleton (p<0.0001) and 
(3)  Cellular  Components  such  as  actin  cytoskeleton 
(p<0.0001), MHC protein complex (p<0.01), cell junc-
tion (p<0.01) as well as other factors (Additional file 4: 
Table S4). Similarly, identification of the inflammation 
mediated  by  chemokine  and  cytokine  signaling 
pathway  (p<0.001)  during  functional  analysis  of  in 
silico data demonstrate potential implications of mi-
crobial-dependent miRNA regulation on the intestinal 
barrier function.  
 
 
Figure 2. Clustering of caecal microRNAs expression profiles in germ-free and conventionally raised mice. The profiles of 
18 transcripts including 16 microRNAs significantly differently expressed (p<0.05, FDR<20%) between germ-free and conventional caecal 
samples were visualized using a supervised heatmap (complete linkage and Euclidean distance metric). Expression values range from +2.5 
log2 to -2.5 log2 of ∆Ct values normalized using mean expression value normalization with positive values (red) indicating higher ex-
pression and negative values (green) indicating lower expression in germ-free versus conventional mice. Dendrograms indicate the 
correlation between groups of samples and genes. Samples are in columns and transcripts in rows. Int. J. Biol. Sci. 2012, 8 
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MiRNA-dependent regulation of the intestinal 
barrier function by the endogenous microbiota 
Considering the results described above, and the 
fact that endogenous microbes play an important role 
in the creation and maintenance of the intestinal bar-
rier we decided to investigate the potential impact of 
the microbiota-responsive miRNAs on the intestinal 
barrier function via analysis of intestinal barrier spe-
cific gene targets. We first compiled a gene set con-
taining  527  genes  involved  in  the  regulation  of  the 
intestinal barrier function, as explained in Materials 
and Methods, which we called the “Intestinal Barrier 
Gene Set”. The list of genes included in this gene set is 
provided as (Additional file 5: Table S5). We then fil-
tered the 2,755 target genes by this pre-defined gene 
set and established all miRNA:target interactions for 
the  remaining  genes.  Using  NAViGaTOR  (Network 
Analysis,  Visualization  and  Graphing  Toronto)  ver. 
2.2 [46], a scalable, network analysis and visualization 
system, we mapped the miRNA network linking our 
identified miRNA of interest in order to examine the 
micronome,  as  described  before  [51]  (Figure  3). 
miR-487b did not have any intestinal barrier targets as 
per the algorithms employed and therefore it does not 
appear  in  the  figure.  Thirty-four  intestinal  barri-
er-related genes were found to be among the potential 
targets  of  the  intestinal  miRNAs  the  expression  of 
which  depends  on  the  endogenous  microbiota,  and 
fifteen  of  these  were  identified  by  both  algorithms. 
These  include  genes  involved  in  glycosylation, 
cell-cell  junction  formation,  the  mucus  layer  and 
genes  involved  in  immune  regulation  particularly 
MHC I and II proteins amongst others. Closer inspec-
tion of this miRNA interaction network reveals sev-
eral genes co-targeted by  the miRNAs identified as 
differentially  expressed  between  the  caecal  miRNA 
signatures in germ-free and conventional mice. For-
min  1  (FMN1)  is  co-targeted  by  2  miRNAs 
down-regulated in the germ-free mice (miR-351 and 
miR-467a)  as  well  as  one  up-regulated  miRNA 
(miR-145). Other genes appearing to be co-targeted by 
multiple  differentially  expressed  miRNAs  are:  Cad-
herin 5 (Cdh5), UDP-N-acetyl-alpha-D-galactosamine: 
polypeptide  N-acetylgalactosaminyltransferase  5 
(Galnt5), poliovirus receptor-related 1 (Pvrl1), fascin 
homolog 1, actin bundling protein (Fscn1), Cingulin 
(Cgn),  glucosaminyl  (N-acetyl)  transferase  1,  core  2 
(Gcnt1)  and  UDP-N-acetyl-alpha-D-galactosamine: 
polypeptide  N-acetylgalactosaminyltransferase  7 
(Galnt7). Of the thirty-four predicted intestinal barrier 
genes targets, twenty had been previously found to be 
expressed in the caeca of C57BL/6 mice (n=2), in mi-
croarray  experiments  with  a  hybridization  signal 
higher than 150 (ATP-binding cassette, sub-family B 
(MDR/TAP)  member  9  (Abcb9),  Nicastrin  (Ncstn), 
Spermidine/spermine N1-acetyl transferase 1 (Sat1), 
Desmoglein 3 (Dsg3), UDP-Gal:betaGlcNAc beta 1,4- 
galactosyltransferase, polypeptide 1 (B4galt1), Leucine 
aminopeptidase  3  (Lap3),  beta-1,3-galactosyl-O- 
glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyl-
transferase  (Gcnt1),  CMP-N-acetylneuraminate-beta- 
1,4-galactoside  alpha-2,3-sialyltransferase  (St3gal3), 
Junction plakoglobin (Jup), Aminopeptidase puromy-
cin  sensitive  (Npepps),  UDP-N-acetyl-alpha-D- 
galactosamine:  polypeptide  N-acetylgalactosaminyl-
transferase  7  (Galnt7),  Plakophilin  1  (Pkp1),  (al-
pha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-a
cetylgalactosaminide  alpha-2,6-sialyltransferase  6 
(St6galnac6),  Carcinoembryonic  antigen-related  cell 
adhesion  molecule  1  (Ceacam1),  Formin-1  (Fmn1), 
Prostasin (Prss8), glycoprotein-N-acetylgalactosamine 
3-beta-galactosyltransferase  1  (C1galt1), 
UDP-Gal:betaGlcNAc  beta  1,4-galactosyltransferase, 
polypeptide  5  (B4galt5),  UDP-Gal:betaGlcNAc  beta 
1,4-  galactosyltransferase,  polypeptide  2  (B4galt2), 
Myosin,  light  polypeptide  kinase  (Mylk)  (Gene  Ex-
pression Omnibus [57] dataset GSE1133 [58]). This list 
is conservative, since not  all of the genes shown in 
Figure 3 had microarray probes.  
Seventy one percent of the genes included in our 
gene set were not considered by PITA and TargetScan 
due to the low conservation of the 3’UTR in homolo-
gous genes. Moreover, this analysis did not incorpo-
rate passenger miRNAs because they are not consid-
ered in PITA and TargetScan databases. Alternatively, 
when  using  MicroCosm  targets  [13]  to  map  these, 
only miR-let7g* had targets remaining after filtering 
with  the  intestinal  barrier  gene  set.  These  are: 
C1GALT1-specific chaperone 1 (C1galt1c1), Claudin-7 
(Cldn7), Histocompatibility 2, class II antigen A, beta 1 
(H2-Ab1),  Pancreatitis-associated  protein  (Pap), 
Phospholipase A2, group  XIIA (Pla2g12a), Phospho-
lipase  A2,  group  IB  (Pla2g1b),  Spermidine  synthase 
(Srm), Thimet  oligopeptidase 1 (Thop1), Toll-like re-
ceptor-11 (Tlr11) and Toll-like receptor-13 (Tlr13). 
Finally, in order to substantiate the hypothesis 
that gut commensals impact the intestinal barrier via 
miRNA expression modulation, we crossed-matched 
our global list of intestinal barrier genes with genes 
previously identified to be differentially expressed in 
the  jejunal  mucosa  of  intestinal-specific  Dicer 
knock-out mice [60]. The result of this analysis pro-
vides  experimental  evidence  that  miRNAs  indeed 
impact  on  barrier-related gene  expression,  with  po-
tential  repercussions  on  its  function.  Of  particular 
interest are intestinal barrier genes from our list that 
were  found  to  be  experimentally  perturbed  (up-  or Int. J. Biol. Sci. 2012, 8 
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down-regulated)  by  the  conditional  knock-out  of 
Dicer [60]. They include: glycosylation enzymes, im-
muno-inflammatory  response  genes,  components  of 
MHC I and II, junctional proteins, mucus layer asso-
ciated  proteins  and  defense  response  proteins,  in-
cluding antimicrobial peptides and Pathogen Associ-
ated Molecular Pattern (PAMP) responsive elements. 
Although,  this  analysis  shows  that  miRNAs  affect 
genes that comprise the intestinal barrier, in order to 
further establish a nexus between microbial induced 
modulation of miRNAs, which in turn affects barrier 
function, we combined putative barrier related gene 
targets of the microbial dependent miRNAs (Figure 3) 
with the Dicer knock-out mice data [60]. Among the 
genes  differentially  expressed  in  the  absence  of 
miRNAs in the jejunal mucosa, we found that seven 
intestinal  barrier  related  genes  were  either 
up-regulated  (glycoprotein-N-acetylgalactosamine 
3-beta-galactosyltransferase 1 (C1galt1), myosin, light 
polypeptide kinase (Mylk), Aminopeptidase puromy-
cin  sensitive  (Npepps),  UDP-N-acetyl-alpha-D- 
galactosamine:  polypeptide  N-acetylgalactosaminyl-
transferase  7  (Galnt7)  and  Prostasin  (Prss8)),  or 
down-regulated  (protein  kinase  C  zeta  isoform  a 
(Prkcz),  beta-1,3-galactosyl-O-glycosyl-glycoprotein 
beta-1,6-N-acetylglucosaminyltransferase  (Gcnt1)). 
More specifically, since these seven genes are in silico 
targets of the miRNAs modulated by the absence or 
presence of the microbiota (germ-free versus conven-
tional  mice)  and  experimental  evidence  points  to  a 
role of epigenetic regulation of these genes via miR-
NAs (Dicer knock-out study) it reiterates a potential 
novel mechanism of host-microbial cross-talk via mi-
crobial  dependent  regulation  of  miRNAs  that  may 
translate into effects on the host with respect to regu-
lation of the intestinal barrier function.  
 
 
Figure 3. Differentially expressed microRNAs impact on the intestinal barrier. MicroRNAs significantly differentially ex-
pressed between germ-free and conventional mice are represented in this diagram by circles, with the colour corresponding to degree of 
differential microRNA expression in germ-free and conventional samples. Expression values range from +2.5 log2 to -2.5 log2 of ∆Ct values 
with positive values (red) indicating higher expression, and negative values (green), indicating lower expression in germ-free versus 
conventional mice. Putative intestinal barrier gene targets as identified by the algorithms TargetScan and PITA are represented by tri-
angles. MicroRNAs with a greater number of intestinal barrier targets are symbolized with a larger circle size. Intestinal barrier gene 
targets that are predicted by both algorithms are indicated by thicker lines. Differentially expressed microRNAs* were not included in the 
diagram as they are not present in both prediction databases. miR-487b did not have any intestinal barrier targets as per the algorithms and 
therefore was excluded from the figure. Int. J. Biol. Sci. 2012, 8 
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Discussion 
Gene  expression  modulation  is  one  of  the 
mechanisms  underlying  the  cross-talk  between  gut 
endogenous  microbiota  and  host  epithelium,  and 
therefore plays a critical role in intestinal homeostasis. 
Here we show that the presence of the microbiota in 
the murine intestinal tract, particularly in the caecum, 
also  associates  with  a  distinctive  miRNA  signature, 
supporting  a  role  for  gut  endosymbionts  in 
post-transcriptional  regulation  of  gene  expression. 
Few studies have looked at the relative expression of 
miRNAs along the cephalocaudal axis of the healthy 
gut, particularly with respect to the passenger miR-
NA* forms, and to the best of our knowledge, this is 
the first study examining  miRNA expression in the 
murine caecum. We found a characteristic micronome 
in the caecum, with 334 miRNA species expressed in 
this region in both germ-free and conventional mice; 
of these, 74 are miRNA* forms. While miRNAs* are 
thought to correspond to the rapidly degraded strand 
of the  miRNA duplex, there is evidence suggesting 
that they may play a so-far unrecognized role within 
cells [24], and in fact may act in a similar fashion to 
guide  strand  miRNAs  in  terms  of  abundance  and 
gene regulation [61].  
Comparison  of  the  global  murine  miRNA  sig-
nature along several intestinal loci, namely the small 
and  large  intestinal  mucosa,  as  well  as  our  caecal 
analysis allows for certain parallels to be drawn. Some 
of the miRNAs belonging to the 15 miRNAs/miRNA 
families  most  expressed  in  the  jejunal  and  colonic 
mucosa [60] are also expressed in the caeca of both 
germ-free  and  conventional  mice  (Additional  file  6: 
Table S6) and 3 (miR-192, miR-378, miR-29a) of the 15 
miRNAs most highly expressed (based on Ct values) 
in the caecum are also expressed in both the jejunum 
and  colon  [60].  Although  diverse  genes  cannot  be 
compared by Ct values, sorting allows for a qualita-
tive measure of the relative level of gene expression 
and to identify genes that do or do not display a re-
gional  expression  pattern  within  the  intestine. 
miR-143 and miR-145 were part of the top expressed 
miRNAs in common between the jejunum and cae-
cum,  and  are  found  in  the  same  genomic  cluster 
(<10kb distance from one another on chromosome 18). 
miR-200b  was  found  in  common  as  a  highly  ex-
pressed miRNA within both the large intestine and 
caecum. Interestingly, other miRNAs with sequence 
similarities to miR-200b were also found to be highly 
expressed,  including  miR-200a  in  the  colon,  and 
miR-200c in the caecum, suggesting that members of 
the miR-8 family play an important physiological role 
in  distal  intestinal  regions.  On  the  other  hand,  19 
miRNAs were found to be expressed in the caecum of 
conventional  mice  (Ct<35)  but  not  in  the  jejunal  or 
colonic mucosa based on the absence of sequence read 
data [60] in either of the two regions (Additional file 6: 
Table  S6),  suggesting  they  may  be  restricted  to  the 
caecum. Intergroup comparisons between germ-free 
and conventional mice illustrate a relatively high de-
gree of similarity between the top miRNAs expressed 
in germ-free and conventional caeca with all 15 of the 
miRNAs with the lowest Ct values overlapping be-
tween  the  two  groups  (Additional  file  6:  Table  S6). 
Moreover, there is a general concordance between the 
murine caecal micronome and the human intestinal 
micronome,  which  incorporates  the  caecum.  Juxta-
posing data on the 13 most highly constitutively ex-
pressed miRNAs in both the terminal ileum and colon 
(caecum, transverse colon, sigmoid colon and rectum) 
from pinch biopsy samples of healthy adults [25] with 
the murine caecal miRNA signature of conventional 
and  germ-free  mice,  revealed  that,  five  miRNAs 
(miR-143, miR-192, miR-200b, miR-200c and miR-24) 
found in the intestines of humans were amongst the 
top 15 mostly highly expressed miRNAs in the mu-
rine  caecum  based  on  Ct  values  (Additional  file  6: 
Table  S6).  Moreover,  miR-19b  which  was  found  to 
have a 3.2-fold higher expression in the caecum ver-
sus the terminal ileum from biopsied samples in hu-
mans, was also found, based on our aforementioned 
analysis, to be part of the 15 most highly expressed 
miRNAs in the murine caecum (germ-free and con-
ventional mice) but not within the jejunal or colonic 
mucosa,  suggesting  this  miRNA  may  exert  a  more 
profound  effect  within  the  caecum.  Although  our 
analysis of miRNA expression between intestinal re-
gions in the mouse is qualitative and cannot be used 
to determine fold differences in expression, it gives 
merit into using the mouse as a model organism to 
investigate intestinal miRNAs as certain parallels can 
be found in humans.  
The expression of these miRNAs may be under 
genetic and environmental control. The latter is par-
ticularly important in the case of the intestine where 
the  epithelium  engages  in  a  continuous  cross-talk 
with the luminal microbes. Here we show that indeed 
the endogenous microbiota contributes to the physi-
ological miRNA signature in the caecum, which re-
sults  in  16  miRNAs  being  differentially  expressed 
between  germ-free  and  conventionally  raised  mice. 
Moreover,  of  these,  miR-133a  and  miR-467a  were 
found to be caecal specific miRNAs when compared 
with  the  jejunum  and  colonic  mucosa  and  miR-145 
was  a  non-selectively  expressed  miRNA  with  high 
levels of expression along the intestine, insinuating a 
role for microbial control of both regional specific and Int. J. Biol. Sci. 2012, 8 
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globally expressed miRNAs that may transcend the 
boundaries of the caecum. Host miRNA modulation 
has been so far observed in response to pathogenic 
insults including prions [62], viruses such as Hepatitis 
B and C [34] and influenza virus [63], bacteria such as 
Helicobacter  pylori  [64],  Francisella  novicida  [65]  and 
Gram  negative  bacteria  LPS  [66],  the  yeast  Candida 
albicans [67] or parasites such as Cryptosporidium par-
vum  [68]  and  Toxoplasma  gondii  [69].  To  our 
knowledge,  the  only  host-microbe  symbiotic  rela-
tionship associated to miRNA modulation in the host 
is  the  legume-rhizobium  symbiosis  [39].  While  we 
used whole-thickness caeca, and therefore could not 
establish the cellular origin of our measured signals, a 
previous  study  revealed  that  at  least  nine  human 
miRNAs  (hsa-miR-145,  hsa-miR-150,  hsa-miR-133a, 
hsa-miR-148a,  hsa-miR-183,  hsa-let-7g*, 
hsa-miR-181a*, hsa-miR-21*, hsa-miR-27b*) that have 
sequence homology with our differentially expressed 
murine miRNA are indeed expressed in colorectal cell 
lines  [24],  suggesting  that  the  intestinal  epithelial 
monolayer  is  susceptible  of  responding  to  the  en-
dogenous  symbionts  or  their  products,  by  miRNA 
modulation. 
To date limited information is available on the 
biological role of these miRNAs; however, several of 
the miRNAs found to be differentially expressed in 
this study are known to be altered in cancer states. 
miR-148a,  which  we  found  to  be  expressed  more 
highly in conventional mice, was found to be more 
highly  expressed  in  tumor  samples  versus  normal 
colonic epithelium [24], while miR-133a and miR-145, 
which  we  found  to  be  more  highly  expressed  in 
germ-free mice, were  shown to exhibit  significantly 
higher  levels  of  expression  in  normal  versus  tumor 
tissues [70,71,72]. There is a general consensus in the 
literature that endogenous gut microbes can alter co-
lon  cancer  susceptibility  and  germ-free  rats  were 
found to develop less and smaller tumors than their 
conventional counterparts when using a protocol that 
induces colorectal cancer [73]. This was attributed to 
enhanced anticancer immune response. In our study, 
a novel pathway may be proposed that incorporates 
microbe  signaling  to  the  host  and  can  alter  the  ex-
pression  of  tumor-suppressors  or  oncogenes 
post-transcriptionally via miRNA regulation. Indeed, 
miR-145 and miR-133a were both predicted by multi-
ple algorithms to target Fascin-1 (FSCN1) (Figure 3), a 
gene  involved  in  actin  cytoskeleton  assembly,  the 
down-regulation of which was experimentally found 
to explain the tumor suppressive effects of miR-145 
and miR-133a in bladder, esophageal squamous cell 
and breast carcinomas [71,74,75].  
However,  inferring  a  microbiota-dependent 
physiological role for differentially  modulated miR-
NA  species  depends  on  the  identification  of  their 
mRNA targets in the caecum. Six of the endogenous 
microbiota-dependent miRNAs were experimentally 
proven  in  previous  studies  to  target  various  genes, 
some  of  which  are  expressed  in  the  caecum.  These 
genes are categorized in various Gene Ontology clas-
ses  including  development,  DNA  binding,  protein 
binding, transcription as well as signaling pathways 
including Wnt receptor signaling suggesting that the 
microbiota  may  be  an  additional  factor  controlling 
these functions. These findings are also in line with 
our  PANTHER  analysis  where  experimentally  vali-
dated targets that are co-expressed in the caecum also 
map to some of the same functions of the targets pre-
dicted in silico.  
Moreover,  PANTHER,  TargetScan  and  PITA 
findings collectively reinforce the role that gut bacte-
ria play in organization of the actin cytoskeleton and 
gut  angiogenesis,  both  previously  shown  to  be  af-
fected by gut bacteria at the transcriptional (mRNA) 
level [9,7,76] suggesting that the impact of gut bacteria 
on specific pathways is many-sided. Particularly, in 
terms  of  angiogenesis,  global  pathway  analysis  of 
targets affected by the microbiota-dependent miRNAs 
illustrate effects on angiogenesis including the process 
of angiogenesis (p= 4.56E-13) itself and the Vascular 
Endothelial Growth Factor (VEGF) signaling pathway 
(p=7.67E-3).  Although  both  the  microbiota  [76]  and 
miRNAs [77] have been independently shown to af-
fect  vascularization,  in  silico  findings  in  this  study 
establish a possible link between them, and demon-
strate a potential mechanism in which the molecular 
dialogue between gut bacteria and the host is carried 
out  to  affect  these  functions.  Gut  bacteria  are  im-
portant  in  the  formation  of  the  intestinal  vascular 
network  during  postnatal  development  [76]  and 
miRNAs in general are known to be developmentally 
regulated. Since the gut microbiota gradually estab-
lishes during postnatal life, it is possible for the two 
processes  to  intertwine.  Indeed,  a  recent  study 
showed that exposure to LPS from endogenous E. coli 
in the developing gut of the murine neonate, results in 
toll-like receptor-4 mediated expression of miR-146a 
and subsequent down-regulation of interleukin-1 re-
ceptor-associated kinase 1 (IRAK1) and the creation of 
an immunologically tolerant environment [78]. Future 
studies could examine the postnatal expression pat-
tern  of  the  differentially  expressed  miRNAs  and  of 
their target genes.  
Several studies have shown microbial dysbiosis 
and miRNA deregulation to be important culprits in a 
number  of  digestive  diseases,  including  irritable Int. J. Biol. Sci. 2012, 8 
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bowel syndrome [36,28] and ulcerative colitis [79,32]. 
Though, it is not understood if and how the two as-
sociate  to  impact  these  conditions.  Based  on  our 
findings, we suggest that deregulation of the micro-
bial  composition  in  digestive  diseases  may  at  least 
partially affect the miRNA expression signature, and 
in turn influence the associated pathologies. One line 
of evidence involves miR-455, which in our study was 
found to be up-regulated in the caecum of germ-free 
mice, and found to target heat-shock factor 1 (hsf1) 
based on bioinformatics analysis. Hsf1 attenuates the 
effects  of  experimentally  induced  colitis  in  mice 
models  via  indirectly  inhibiting  the  production  of 
pro-inflammatory  cytokines,  cellular  apoptosis  and 
cell adhesion molecule induction [80]. Although the 
authors did not take into account both the microbiota 
and miRNAs in these mice models we speculate that 
altered microbial composition in these disease states 
may affect miRNAs that in turn impact on hsf1 with 
potential  repercussions  on  gastrointestinal  disease 
states.  
In both a healthy situation and disease state one 
of the primary lines of defense in the gastrointestinal 
tract is the intestinal barrier, of which the gut micro-
biota is a critical component. Though, at the same time 
gut microbes act as a regulator of the barrier function 
at the mRNA  level, by  impacting the expression  of 
several genes. Recently, genes regulating the intesti-
nal barrier were found to be differentially expressed 
in the jejunum of intestinal-specific Dicer knock-out 
mice, highlighting a role for intestinal miRNAs in the 
regulated expression of intestinal barrier genes [81]. In 
line  with  this  finding,  we  found  that  a  number  of 
genes included in our intestinal barrier gene set are 
indeed  regulated  post-transcriptionally  in  Dicer 
knock-out  mice  and  therefore  depend  on  miRNAs. 
Interestingly, these genes are also the potential targets 
of  gut  microbiota-dependent  miRNAs  (Figure  3). 
These  were  identified  despite  a  stringent  approach 
excluding 376 of our intestinal barrier genes which are 
not reported in the PITA and TargetScan databases. 
Further supporting the existence of an intestinal bar-
rier  regulatory  network  involving  miRNAs  and  the 
gut  microbiota,  some  of  the  intestinal  barrier  genes 
targeted by our selected miRNAs were found to be 
up- or down-regulated in Dicer 1-deficient mice ver-
sus controls [60], suggesting that the microbiota can 
indirectly  impact  on  the  intestinal  barrier 
post-transcriptionally via miRNA regulation. Though, 
it  is  important  to  note  that  in  this  study  we  used 
whole thickness tissues in order to obtain a compre-
hensive evaluation of the intestinal miRNA signature 
response to the commensals.  
Physiologically, the basis of this dialogue has yet 
to be established; nonetheless, an emerging concept 
incorporates  the  utilization  of  toll-like  receptors 
(TLRs) as potential mediators. For example, miR-147 
was found to respond to LPS stimulation of TLR4 in 
murine  peritoneal  macrophages,  resulting  in  an  at-
tenuated release of Interleukin-6 (IL-6) and Tumour 
Necrosis  Factor  alpha  (TNF-α)  [82].  Moreover, 
miR-146a  was  also  reported  to  dampen  the  inflam-
matory response upon up-regulation through PAMP 
activated  TLRs  [83,33].  In  turn,  these  studies  show 
applicability of microbial alterations in miRNA which 
can impact the barrier function. Therefore, it seems 
plausible that TLRs which are localized at the inter-
face between the microbiota and the molecular ma-
chinery of host cells may be a potential facilitator of 
this communication. 
In summary, this study shows that the murine 
caecum expresses a large variety of miRNAs, sixteen 
of which exhibit differential expression in the pres-
ence  or  absence  of  the  endogenous  microbiota. 
Therefore, gut bacteria may impact on intestinal gene 
regulation not only at the transcriptional level but also 
post-transcriptionally; thus, contributing to intestinal 
homeostasis through fine-tuning gene expression. By 
modulating miRNAs, the gut microbiota may affect a 
much larger number of genes than so far expected, 
particularly in a disease situation where the microbi-
ota composition is altered towards less desirable spe-
cies. In this perspective, abnormally expressed miR-
NAs could be considered novel therapeutic targets. 
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